ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

nintedanib

Also written as “Nintedanib”, “BIBF 1120” and “Nintedanib (BIBF1120)”.

Its studies are mostly in Idiopathic Pulmonary Fibrosis · Carcinoma, Non-Small-Cell Lung · Pulmonary Fibrosis · Lung Diseases, Interstitial · Neoplasms, led by 3 companies.

Drug pageNintedanib: every studyAll 141 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Oct 16, 201564 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Boehringer Ingelheim620 open or runningphase 4since Oct 16, 2015Aug 9, 2007none ahead
Mannkindits history only10 open or runningphase 1since Jan 7, 2026Jan 7, 2026none ahead
PureTechits history only10 open or runningphase 1since Nov 20, 2024Nov 20, 2024none ahead

Also a collaborator on its studies: Novotech (Australia) Pty and Parexel.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Boehringer Ingelheim only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 45 studies since Jul 3, 2008.

  1. Nov 16, 2015Phase 4 study in Idiopathic Pulmonary FibrosisNCT02606877 · 37 enrolled · United Kingdom
  2. Jan 21, 20162 phase 1 studiesNCT02667704, NCT02668393
  3. Apr 22, 2016Phase 1 study in Carcinoma, Non-Small-Cell LungNCT02751385 · 2 enrolled · Germany
  4. May 20, 2016Phase 2 study in Colorectal NeoplasmsNCT02780700 · 1 enrolled · United States
  5. May 27, 2016Phase 4 study in Idiopathic Pulmonary FibrosisNCT02788474 · 347 enrolled · United States, Australia, Belgium and more
  6. Dec 19, 2016Phase 3 study in Lung Diseases, InterstitialNCT02999178 · 663 enrolled · United States, Argentina, Belgium and more
  7. Oct 13, 2017Phase 3 study in Lung Diseases, InterstitialNCT03313180 · 444 enrolled · United States, Argentina, Australia and more
  8. Sep 17, 2018Phase 1 study in Scleroderma, SystemicNCT03675581 · 17 enrolled · Belgium, France, Germany and more
  9. Jan 28, 2019Phase 3 study in Lung Diseases, InterstitialNCT03820726 · 435 enrolled · United States, Argentina, Belgium and more
  10. Sep 16, 2019Phase 3 study in Lung Diseases, InterstitialNCT04093024 · 39 enrolled · United States, Argentina, Australia and more
  11. Jun 23, 2021Phase 1 study in HealthyNCT04938453 · 20 enrolled · Germany
  12. Sep 30, 2021Phase 3 study in Lung Diseases, InterstitialNCT05065190 · 81 enrolled · China
  13. Mar 10, 2022Phase 3 study in Lung Diseases, InterstitialNCT05285982 · 54 enrolled · United States, Argentina, Belgium and more
  14. Oct 2, 2023Phase 1 study in HealthyNCT06070610 · 14 enrolled · Germany

TargetBeta

“Platelet-derived growth factor receptor inhibitor; Vascular endothelial growth factor receptor inhibitor; Fibroblast growth factor receptor inhibitor”ChEMBL 37, by rule

Studies

The newest 60 of 62 Boehringer Ingelheim leads. Each opens its study page. Every study on its drug page →

StudyPhaseStatusPrimary completionSize
NCT06070610Healthy · Germany1CompletedDec 14, 202314
NCT05285982Lung Diseases, Interstitial · United States, Argentina, Belgium and more3CompletedAug 13, 202554
NCT05065190Lung Diseases, Interstitial · China3CompletedApr 30, 202481
NCT04938453Healthy · Germany1CompletedAug 30, 202120
NCT04093024Lung Diseases, Interstitial · United States, Argentina, Australia and more3CompletedMay 24, 202239
NCT03820726Lung Diseases, Interstitial · United States, Argentina, Belgium and more3CompletedAug 30, 2022435
NCT03675581Scleroderma, Systemic · Belgium, France, Germany and more1CompletedOct 9, 201917
NCT03313180Lung Diseases, Interstitial · United States, Argentina, Australia and more3CompletedJan 25, 2023444
NCT02999178Lung Diseases, Interstitial · United States, Argentina, Belgium and more3CompletedApr 23, 2019663
NCT02788474Idiopathic Pulmonary Fibrosis · United States, Australia, Belgium and more4CompletedAug 4, 2017347
NCT02780700Colorectal Neoplasms · United States2TerminatedSep 9, 20161
NCT02751385Carcinoma, Non-Small-Cell Lung · Germany1TerminatedNov 28, 20172
NCT02668393Carcinoma, Non-Small-Cell Lung · France, Germany1CompletedNov 27, 201914
NCT02667704Healthy · Germany1CompletedMar 201613
NCT02606877Idiopathic Pulmonary Fibrosis · United Kingdom4CompletedMar 22, 201737
NCT02579603Idiopathic Pulmonary Fibrosis · United States, Canada, France and more4CompletedJan 3, 2017105
NCT02597933Scleroderma, Systemic · United States, Argentina, Australia and more3CompletedOct 31, 2018580
NCT02572752Healthy · Germany1CompletedNov 201570
NCT02300298Carcinoma, Non-Small-Cell Lung · Japan1CompletedJan 15, 201610
NCT02231164Carcinoma, Non-Small-Cell Lung · United States, Georgia, Thailand3TerminatedDec 24, 201512
NCT02191865Hepatic Insufficiency · Germany1CompletedDec 201433
NCT02182258Healthy1CompletedAug 200930
NCT02182245Genital Neoplasms, Female1CompletedJan 1, 200722
NCT02182219Prostatic Neoplasms1CompletedApr 1, 200721
NCT02182206Neoplasms1CompletedJun 200550
NCT02182193Healthy1CompletedNov 200654
NCT02182154Healthy1CompletedNov 20058
NCT02182141Multiple Myeloma1CompletedMar 200517
NCT02182128Neoplasms1CompletedJun 200924
NCT02182102Carcinoma, Non-Small-Cell Lung1CompletedMay 201026
NCT02182076Healthy1CompletedNov 200515
NCT02182063Prostatic Neoplasms2CompletedJan 200781
NCT02182050Carcinoma, Non-Small-Cell Lung2CompletedJan 200773
NCT02149108Colorectal Neoplasms · United States, Argentina, Australia and more3CompletedMay 13, 2016768
NCT01979952Idiopathic Pulmonary Fibrosis · United States, Canada, Turkey3CompletedOct 27, 2016113
NCT01951846Malignant Solid Tumour · Germany1CompletedNov 200461
NCT01907100Mesothelioma · United States, Argentina, Australia and more3TerminatedMar 16, 2018545
NCT01770392Healthy · Germany1CompletedMar 201326
NCT01679613Healthy · Germany1CompletedNov 201234
NCT01619085Idiopathic Pulmonary Fibrosis · United States, Australia, Belgium and more3CompletedJul 5, 2017752
NCT01594125Carcinoma, Hepatocellular · Japan1CompletedNov 201430
NCT01417156Pulmonary Fibrosis · Japan2CompletedOct 201520
NCT01346540Carcinoma, Non-Small-Cell Lung · Italy, Netherlands, Spain and more1CompletedApr 25, 201316
NCT01335477Pulmonary Fibrosis · United States, Canada, Chile and more3CompletedOct 2013551
NCT01335464Pulmonary Fibrosis · United States, Australia, Belgium and more3CompletedOct 2013515
NCT01170065Pulmonary Fibrosis · Argentina, Australia, Belgium and more2CompletedSep 26, 2016198
NCT01136174Idiopathic Pulmonary Fibrosis · Japan2CompletedMar 201150
NCT01022853Neoplasms · Italy1CompletedFeb 201330
NCT01024920Carcinoma, Renal Cell · Hungary, Poland, Romania and more2CompletedNov 8, 201199
NCT01015118Ovarian Neoplasms · United States, Australia, Austria and more3CompletedApr 1, 20131,366
NCT00998296Neoplasms · France1CompletedDec 201270
NCT01004003Carcinoma, Hepatocellular · Austria, France, Germany and more2CompletedJul 14, 2014125
NCT00987935Carcinoma, Hepatocellular · Korea, Republic of, Taiwan2CompletedJul 2014134
NCT00979576Carcinoma, Non-Small-Cell Lung · Japan1TerminatedFeb 16, 201519
NCT00806819Carcinoma, Non-Small-Cell Lung · United States, Argentina, Australia and more3CompletedJun 2011718
NCT00805194Carcinoma, Non-Small-Cell Lung · Austria, Belarus, Belgium and more3CompletedNov 2, 20101,314
NCT00801294Colorectal Neoplasms · France2CompletedNov 1, 200746
NCT00730821Neoplasms · United States1CompletedAug 200928
NCT00715403Neoplasms · France, Germany1CompletedSep 200941
NCT00710762Ovarian Neoplasms · United Kingdom2CompletedSep 200889

How it is read

Names in the registry

  • “Nintedanib”, 43 entries
  • “BIBF 1120”, 26 entries
  • “nintedanib”, 4 entries
  • “Nintedanib (BIBF1120)”, 2 entries
  • “Nintedanib high dose”, 2 entries

Codes read as this program: MNKD201.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.